MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Penumbra Total Non Current Liabilities 2011-2026 | PEN
Annual Total Non Current Liabilities Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 89.2 M | 26.5 M | 24.7 M | 5.91 M | 3.18 M | 113 M | 63.4 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 113 M | 3.18 M | 46.5 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.38 | -1.83 % | $ 722 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.08 | -1.3 % | $ 325 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.43 | -5.02 % | $ 6.74 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Outset Medical
OM
|
436 M | $ 3.48 | -1.56 % | $ 52.9 K | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 36.39 | -1.73 % | $ 1.13 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Sensus Healthcare
SRTS
|
1.66 M | $ 4.05 | -4.03 % | $ 66.1 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
8.87 K | $ 24.53 | -0.53 % | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
13 B | $ 331.46 | 1.19 % | $ 127 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | -9.13 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.33 | 0.43 % | $ 3.64 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 63.53 | 0.36 % | $ 3.47 B |  Britain |
 |
InspireMD
NSPR
|
3.49 M | $ 1.76 | 0.29 % | $ 113 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 11.34 | -0.44 % | $ 1.53 B | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 23.43 | -3.44 % | $ 1.59 B | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.94 | -4.02 % | $ 582 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.75 | 7.97 % | $ 35.2 M | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
275 K | $ 0.68 | -2.24 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 50.39 | -1.98 % | $ 1.48 B | USA |
 |
Viemed Healthcare
VMD
|
14.6 M | $ 9.25 | -1.11 % | $ 360 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.26 | -2.69 % | $ 51.3 M | USA |
 |
Varex Imaging Corporation
VREX
|
419 M | $ 10.71 | 0.19 % | $ 443 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
763 M | - | - | $ 2.07 B | USA |